Skip to main content
Naturally Splendid Enterprises Ltd. logo

Naturally Splendid Enterprises Ltd. — Investor Relations & Filings

Ticker · NSP ISIN · CA63902L2093 LEI · 5493004EEQ2ZUPT66B04 TSXV Manufacturing
Open in API
Filings indexed 544 across all filing types
Latest filing 2020-08-29 Regulatory Filings
Country CA Canada
Listing TSXV NSP

About Naturally Splendid Enterprises Ltd.

www.naturallysplendid.com

Naturally Splendid Enterprises Ltd. develops, produces, and distributes healthy lifestyle foods and plant-based commodity products within the natural food and superfood industry. The company specializes in functional food products and ingredients, with a significant focus on hemp-based formulations. Naturally Splendid serves both commercial processors and end consumers, offering products under established brands such as Natera Sport, Natera Hemp Foods, CHII, and Elevate Me. A key operational component is contract manufacturing, utilizing a Safe Quality Food (SQF) Level 2 certified food manufacturing facility. The company is positioned as a manufacturer specializing in plant-based ingredients and functional foods.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CFO regarding the interim financial reports and interim MD&A for the period ended June 30, 2020. It is a Form 52-109FV2 Certification of interim filings for a venture issuer. The content is primarily an officer certification attesting to the accuracy and fair presentation of the interim filings, without containing the actual financial data or analysis itself. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is short (3005 characters), and it does not contain substantive financial statements or detailed financial analysis, confirming it is a certification rather than a full interim report.
2020-08-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of interim filings for a venture issuer, signed by the CEO. It certifies the review and fair presentation of interim financial reports and interim MD&A for the period ended June 30, 2020. The content is primarily an officer certification letter, confirming the accuracy and completeness of the interim filings, without containing actual financial data or substantive financial analysis. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself. The document length is short (3005 characters), and it is clearly a certification rather than a full interim report or financial statement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-08-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the six months ended June 30, 2020, which is a typical component of an interim or quarterly report. It references unaudited consolidated interim financial statements prepared under IFRS, indicating it is a comprehensive financial report for a period shorter than a full fiscal year. The content includes detailed discussion of business operations, strategy, acquisitions, product lines, and financial arrangements, consistent with an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains substantive financial and operational information, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2020
2020-08-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed unaudited consolidated interim financial statements for the six months ended June 30, 2020, including statements of financial position, loss and comprehensive loss, changes in cash flow, and management's comments. It is explicitly titled as "Consolidated Interim Financial Statements (Unaudited – Prepared by Management)" and dated August 28, 2020. The presence of comprehensive financial data for a period shorter than a full fiscal year (six months) and the inclusion of management commentary aligns with the definition of an Interim / Quarterly Report (IR). The document is substantive and not merely an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is IR with high confidence. H1 2020
2020-08-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Naturally Splendid Enterprises Ltd. announcing that Health Canada has requested protocol details for a Phase 2 clinical trial of their drug candidate Cavaltinib for COVID-19 treatment. The text discusses the clinical trial application process, regulatory interactions, and the drug's potential benefits. There is no financial data, no mention of financial results, no detailed report or presentation, and no regulatory filing or certification. The document is an announcement about regulatory progress and clinical trial protocol submission, not a financial or governance report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a regulatory update related to clinical trial progress and regulatory approval steps, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-08-10 English
News release - English.pdf
Regulatory Filings
2020-07-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.